SCHEMBL6924495

SCHEMBL6924495

NC(=O)c1c(C2CCCCC2)nc2ccccc2c1N

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 4/20 0.49
TDP1 Q9NUW8 2/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
BCHE P06276 1/20 0.49
HSD17B10 Q99714 2/20 0.48
TP53 P04637 1/20 0.48
ATM Q13315 1/20 0.46
CHRNA7 P36544 1/20 0.46
DHODH Q02127 1/20 0.43
LCK P06239 1/20 0.43
MAP2K3 P46734 1/20 0.43
MAP2K6 P52564 1/20 0.43
BTK Q06187 1/20 0.43
MAP3K19 Q56UN5 1/20 0.43
NEK10 Q6ZWH5 1/20 0.43
ALDH1A1 P00352 3/20 0.43
KCNH2 Q12809 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2C9 P11712 1/20 0.43
TSHR P16473 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6924491 0.80 ATM (0.45) ACHETDP1L3MBTL1HSD17B10ATM
SCHEMBL28280694 0.78 ACHE (0.50) ACHEBCHEHSD17B10TP53ALDH1A1
SCHEMBL28281977 0.76 KDM4E (0.50) ACHEL3MBTL1BCHEHSD17B10TP53
SCHEMBL28263786 0.74 L3MBTL1 (0.66) ACHETDP1L3MBTL1BCHEATM
SCHEMBL560134 0.73 L3MBTL1 (0.65) ACHETDP1L3MBTL1BCHEHSD17B10
SCHEMBL13861857 0.73 PRKAA2 (0.65) ACHEBCHEDHODHALDH1A1GAA
SCHEMBL4703657 0.71 TDP1 (0.58) ACHETDP1L3MBTL1BCHEHSD17B10
SCHEMBL9107151 0.71 ACHE (0.82) ACHETDP1BCHEHSD17B10TP53
SCHEMBL9770657 0.70 KDM4E (0.49) ACHETDP1L3MBTL1BCHEHSD17B10
SCHEMBL15621993 0.70 HRH2 (0.43) KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004087669-A1 NOVEL QUINOLINE, TETRAHYDROQUINAZOLINE, AND PYRIMIDINE DERIVATIVES AND METHODS OF TREATMENT RELATED TO THE USE THEREOF TAISHO PHARMACEUTICAL CO. LTD. (JP) 2004-10-14 WO disclosed